Seaniemac International Inc (BETS) 0.0014

New Post Public Reply Private Reply Replies (0) Message Board

Apr 11, 2016 at 11:08 PM

Seaniemac International Inc (BETS) 0.0014 $BETS

SeanieMac Signs Leek Out Agreement With Apollo Capital
ACCESSWIRE - Wed Mar 30, 9:06AM CDT
HUNTINGTON, NY / ACCESSWIRE / March 30, 2016 / SeanieMac International (OTC: BETS) and Apollo Capital (No relation to ApolloBet UK) have executed a legally binding leek out agreement, which restrict the amount of shares that Apollo Capital can sell in any week to 18.5% of the dollar volume of the prior week.

SeanieMac Addresses Shareholders and Exciting Future
ACCESSWIRE - Mon Mar 28, 8:52AM CDT
HUNTINGTON, NY / ACCESSWIRE / March 28, 2016 / In response to numerous shareholders requests, SeanieMac has had discussions with it's noteholders to determine a reasonable solution that addresses concerns that uncontrolled conversions could have a negative effect on share price. This is done with the understanding that the convertible lender can realize their contractual return in exchange for providing capital that has enabled us to get current and help us achieve substantial developments (soon to be announced ) to position this Company to rapidly grow and increase Shareholder value.

Seanimac Announces Record Revenues and Scores Big With Merger
ACCESSWIRE - Wed Mar 23, 9:17AM CDT
SeanieMac Holdings UK merges ApolloBet UK and SeanieMac Ireland, While Generating $600,000 in Gross Revenue Last Week

SeanieMac International Ltd to file 10-k
ACCESSWIRE - Thu Apr 16, 7:48AM CDT
HUNTINGTON, NY / ACCESSWIRE / April 16, 2015 / SeanieMac plans to file its 10-k shortly. We do not expect a substantial delay The delay is not with our auditor but with our US based accountants hired to prepare the materials for the auditor. We are pressing to complete the process as quickly as possible. We do not anticipate any material difference between our audited numbers and the numbers provided to investors in prior press releases.

SeanieMac International Ltd 1st Quarter Revenue, Gross Profit and New Users Update
ACCESSWIRE - Wed Apr 15, 8:01AM CDT
HUNTINGTON, NY / ACCESSWIRE / April 15, 2015 / SeanieMac International Ltd, (PINKSHEETS:BETS), reports preliminary results for the 1st quarter ending March 31, 2015.

SeanieMac International, Ltd. Announces WHC Capital LLC Issued Final Conversion Notice.
ACCESSWIRE - Tue Mar 24, 11:58AM CDT
SeanieMac International LTD. announced today that WHC LLC issued its Final Conversion on its Convertible Debenture

SeanieMac International, Ltd. Announces LG Capital Funding LLC Issued Final Conversion Notice
ACCESSWIRE - Mon Mar 16, 7:44AM CDT
HUNTINGTON, NY / ACCESSWIRE / March 16, 2015 / SeanieMac International Ltd. (PINKSHEETS:BETS) announced today that LG Capital Funding II, LLC has issued A Final Conversion on its Convertible Debenture issued July 14, 2014.

SeanieMac International, Ltd. Launches Internal Pay-Per-Click Marketing Program
ACCESSWIRE - Thu Mar 12, 2:15PM CDT
HUNTINGTON, NY / ACCESSWIRE / March 12, 2015 / As part of its focused effort to attract more customers SeanieMac International, Ltd. (OTC:BETS) announced it will be launching a weekly in house pay per click marketing program, funded by its JV partners. Garreth Core, COO will manage the program in house beginning next week. Initially 100k will be allocated to this weekly effort for 2015.

SeanieMac International, Ltd. Announces Redwood Fund II LLC Convertible Debentures Have Been Fully Converted and/or Purchased
ACCESSWIRE - Tue Mar 10, 9:00AM CDT
HUNTINGTON, NY / ACCESSWIRE / March 10, 2015 / SeanieMac International LTD. announced today that Redwood Fund II, LLC $75,000 Convertible Debenture have been fully converted and purchased for cash.

SeanieMac International, Ltd. Signs JV Agreement to Issue a Real Time BitCoin Debit Card with a Major International Credit Card
ACCESSWIRE - Tue Mar 10, 8:32AM CDT
HUNTINGTON, NY / ACCESSWIRE / March 10, 2014 / SeanieMac announced today that it had signed an joint venture to issue a branded debit card under a major international credit card brand. We will be updating shareholders as we get closer to issuing debit cards and sign additional agreements on the Joint Venture.

SeanieMac International, Ltd. January update
PR Newswire - Tue Feb 03, 9:52AM CST
In a strong start to 2015 SeanieMac International (OTC: BETS) announced that January 2015 was its most profitable month since its launch in 2013.

SeanieMac International, Ltd. Announces Exclusive Marketing Agreement with Overseas BC Marketing Inc. Permitting Bitcoin Wagering
PR Newswire - Fri Jan 30, 9:16AM CST
SeanieMac International, Ltd. (OTCQB: BETS) announced that it has entered into an exclusive marketing agreement with Overseas BC Marketing, Inc. ("OBCMI"

pursuant to which OBCMI will market SeanieMac's online web-based waging services and products. The marketing agreement will provide a platform that allows for revenue sharing on new accounts generated by OBCMI. This platform will allow customers to use bitcoin for wagering by interfacing with SeanieMac's wagering platform. SeanieMac believes this will appeal to many customers, due to the prevalence of bitcoin use overseas.

SeanieMac International, Ltd. Signs credit line for $5 million in financing
PR Newswire - Mon Jan 26, 11:06AM CST
SeanieMac International, Ltd. (OTCQB: BETS) announced that it signed an agreement for a credit facility of $5 million dollars. The credit facility can be repaid in shares but only at the direction of the Company and only at prices approved by the Company and when directed by the Company at 90 percent of market value at the time of conversion. There is no fee to start the line, no open ended conversion feature and no "toxic" feature whereby the lender can continue to convert at lower and lower prices. The Company and the lender have estimated the average conversion price for the entire facility at 6.25 cents for the purposes of regulatory filings.

SeanieMac International, Ltd. Current in Financial Filings; CEO Provides Shareholder Update on 2014 Financial Performance
PR Newswire - Wed Jan 14, 7:30AM CST
SeanieMac International, Ltd (OTCQB: BETS), announces it is has regained OTCQB status, after becoming current in its SEC filings with the filing of its 3rd quarter results on December 31, 2014. The CEO also provided the following update:

SeanieMac Announces Shareholder Update
Marketwire - Mon Oct 06, 5:48AM CDT
SeanieMac (PINKSHEETS: BETS)

SeanieMac International Ltd Appoints Shane O'Driscoll as CEO, Garreth Core as COO
Marketwire - Tue Sep 09, 6:06PM CDT
SeanieMac International (PINKSHEETS: BETS) announced they had formalized the appointments of Shane O'Driscoll as CEO and Garreth Core as COO of SeanieMac Ltd.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Photocure Navigates AssureMDx's Medicare Journey

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Segway Powersports Ventures into Baja 1000: Ambitions Run High

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

UAE Pioneers eATA Carnet System Beyond Europe

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Valmet Expands Board Maker Deal in Asia With New Line

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

AI Agents Redefine Finance: Deutsche & Ant Tech

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...